|
ABT
|
Abbott Laboratories
|
US
|
NYSE
|
|
ABUS
|
Arbutus Biopharma Corporation
|
US
|
NASDAQ
|
|
ACST
|
Acasti Pharma, Inc.
|
US
|
NASDAQ
|
|
ALKS
|
Alkermes plc
|
US
|
NASDAQ
|
|
AMRN
|
Amarin Corporation plc
|
US
|
NASDAQ
|
|
ARGX
|
argenx SE
|
US
|
NASDAQ
|
|
CBAY
|
CymaBay Therapeutics Inc.
|
US
|
NASDAQ
|
|
ESPR
|
Esperion Therapeutics, Inc.
|
US
|
NASDAQ
|
|
GBIO
|
Generation Bio Co.
|
US
|
NASDAQ
|
|
GLMD
|
Galmed Pharmaceuticals Ltd.
|
US
|
NASDAQ
|
|
HEPA
|
Hepion Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
IONS
|
Ionis Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
MDGL
|
Madrigal Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
NEPT
|
Neptune Technologies & Bioresources Inc
|
US
|
NASDAQ
|
|
PDSB
|
PDS Biotechnology Corporation
|
US
|
NASDAQ
|
|
PLXP
|
PLx Pharma Inc.
|
US
|
NASDAQ
|
|
PYPD
|
PolyPid Ltd.
|
US
|
NASDAQ
|
|
RIBT
|
RiceBran Technologies
|
US
|
NASDAQ
|
|
TARA
|
ArTara Therapeutics, Inc.
|
US
|
NASDAQ
|
|
VERV
|
Verve Therapeutics, Inc.
|
US
|
NASDAQ
|